Quarterly report · Q1
7446.TEDINET S100ST6L
Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.3bn | 2023-10-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥35.1bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.4bn | 2022-10-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥58m | 2023-10-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥254m | 2022-10-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥78m | 2023-10-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥808m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥271m | 2022-10-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥90m | 2023-10-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥271m | 2022-10-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥53m | 2023-10-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥556m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥182m | 2022-10-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥53m | 2023-10-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥187m | 2022-10-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥19.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥18.9bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥19.2bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.4bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥11.7bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.3bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2023-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥59.34 | 2023-10-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥617.29 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥202.31 | 2022-10-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥518m |
| jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥518m |
| jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥4.2bn |
| jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥4.2bn |
| jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥3.6bn |
| jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥3.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2023-12-31 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2023-12-31 | ¥8.3bn |
| jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥552m |
| jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥552m |
| jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.3bn |
| jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2022-12-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2022-12-31 | ¥9.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 365
| Item | Context | Value | Unit |
|---|---|---|---|
| Assets | Prior1YearInstant | 18920740000 | JPY |
| Assets | CurrentQuarterInstant | 19681740000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 9588734000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 9942883000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 371971000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 344537000 | JPY |
| Short term loans payable | Prior1YearInstant | 233400000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 250800000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 14280000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 14280000 | JPY |
| Lease obligations cl | Prior1YearInstant | 99378000 | JPY |
| Lease obligations cl | CurrentQuarterInstant | 140845000 | JPY |
| Accounts payable other | Prior1YearInstant | 158886000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 176421000 | JPY |
| Income taxes payable | Prior1YearInstant | 100298000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 16592000 | JPY |
| Provision for bonuses | Prior1YearInstant | 57450000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 12300000 | JPY |
| Other cl | Prior1YearInstant | 248553000 | JPY |
| Other cl | CurrentQuarterInstant | 387574000 | JPY |
| Current liabilities | Prior1YearInstant | 10872953000 | JPY |
| Current liabilities | CurrentQuarterInstant | 11286235000 | JPY |
| Long term loans payable | Prior1YearInstant | 27410000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 23840000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 201836000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 504096000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 282841000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 325246000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 80365000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 78825000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 142012000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 110898000 | JPY |
| Other ncl | Prior1YearInstant | 44232000 | JPY |
| Other ncl | CurrentQuarterInstant | 74909000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 778697000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 1117815000 | JPY |
| Liabilities | Prior1YearInstant | 11651650000 | JPY |
| Liabilities | CurrentQuarterInstant | 12404051000 | JPY |
| Capital stock | Prior1YearInstant | 820400000 | JPY |
| Capital stock | CurrentQuarterInstant | 820400000 | JPY |
| Capital surplus | Prior1YearInstant | 881100000 | JPY |
| Capital surplus | CurrentQuarterInstant | 881100000 | JPY |
| Retained earnings | Prior1YearInstant | 4946792000 | JPY |
| Retained earnings | CurrentQuarterInstant | 4905926000 | JPY |
| Treasury stock | Prior1YearInstant | -168907000 | JPY |
| Treasury stock | CurrentQuarterInstant | -168907000 | JPY |
| Shareholders equity | Prior1YearInstant | 6479385000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 6438519000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 697779000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 748000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |